Warning: The NCBI web site requires JavaScript to function. more...
Department of Psychiatry, University of Pittsburgh, Pennsylvania, USA.
Pharmacotherapy for patients with borderline personality disorder is directed against the psychobiology of cognitive-perceptual, affective, and impulsive-behavioral symptoms. A symptom-specific method using current empiric evidence for drug efficacy in each symptom domain is proposed. Drugs in each medication class have some potential utility against specific symptoms in patients with borderline personality disorder.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on